Research Project
Grant-in-Aid for Challenging Exploratory Research
The EGFR mutation test was first introduced into the mutation testing in lung cancer. The fundamental know-hows for the mutation testing have been established therefore. It is not always easy to isolate samples from the patients with serious conditions. Accordingly, the liquid biopsy tests that investigate DNA fragments residing in urine or in blood. We have established a next-generation sequencer-based mutation test called MINtS. We apply the liquid biopsy samples to MINtS in the current study. MINtS enables to test multiple samples in a single sequencing run. The sensitivity and specificity for a single gene is raised to 0.999 and achieved the sensitivity and specificity >0.99 as a whole We consider that MINtS is a prototype of genetic tests that have favorable characteristics suitable for clinical medicine.
All 2017 2016
All Journal Article (2 results) (of which Peer Reviewed: 1 results, Open Access: 1 results) Presentation (3 results)
PLoS One
Volume: 12(4) Issue: 4 Pages: 1-14
10.1371/journal.pone.0176525
呼吸器内科
Volume: 29 Pages: 191-194